Recommendations for essential medicines for multiple sclerosis in low-resource settings.
Saylor D, Rijke N, McDonell J, Laurson-Doube J, Avasarala J, Baldin E, Banerjee TK, Bogdanovic I, Bove R, Chawla DK, Costello K, Del Giovane C, Abkari NE, Filippini G, Foschi M, Gonzalez-Lorenzo M, Helme A, Jacobs D, Kalincik T, Mantel-Teeuwisse A, Minozzi S, Navas C, Nonino F, Ojo OO, Ozcan B, Pasi E, Peryer G, Prato Chichiraldi A, Ridley B, Sokhi DS, Traboulsee A, Tramacere I, Tye JS, Vecchi S, Viswanathan S, Xie F, Zeineddine M, Schunemann H, Piggott T.
Saylor D, et al. Among authors: piggott t.
Mult Scler. 2025 Apr;31(4):464-473. doi: 10.1177/13524585241308134. Epub 2024 Dec 31.
Mult Scler. 2025.
PMID: 40167177
Free article.